EP2265125
TOPICAL LFA-1 ANTAGONISTS FOR USE IN LOCALIZED TREATMENT OF IMMUNE RELATED DISORDERS
:
EP einkaleyfi: Þýðing ekki lögð inn:
15.4.2009:
14.8.2019:
09733509.5
:
14.4.2029
:
TOPICAL LFA-1 ANTAGONISTS FOR USE IN LOCALIZED TREATMENT OF IMMUNE RELATED DISORDERS
15.4.2009
14.8.2019
:
SARcode Bioscience Inc.:
1000 Marina Blvd., Suite 250, 94005, Brisbane, CA, US
:
BURNIER, John:
PacificaCA, US
:
GADEK, Thomas:
OaklandCA, US
:
45240:
15.4.2008:
US
:
US2009002389:
15.4.2009
:
A01N 55/02, A61K 31/555, A61K 31/472, A61K 31/4725, A61K 38/13, A61P 11/00, A61P 17/00, A61P 17/06, A61P 17/14, A61P 29/00, A61P 19/02, A61K 9/00